Notable Analyst Rating Changes 10/01: (MDRX) (GILD) (CWTR) Upgraded; (MSFT) (PHM) (ALU) Downgraded

October 1, 2012 11:00 AM EDT Send to a Friend
Get Alerts MDRX Hot Sheet
Trade MDRX Now!
UPGRADES
Allscripts (Nasdaq: MDRX) boosted by two today:
  • ISI Group from Market Weight to Overweight; and

  • Cowen from Neutral to Outperform.
Bernstein upgrades Gilead Sciences (Nasdaq: GILD) from Market Perform to Outperform.

Piper Jaffray lifts Coldwater Creek, Inc. (Nasdaq: CWTR) from Neutral to Overweight, doubling its price target to $2.

Tudor Pickering raises Hercules Offshore (Nasdaq: HERO) from Hold to Accumulate.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
RBC Capital downgrades Microsoft (Nasdaq: MSFT) from Outperform to Sector Perform, trimming its price targe from $34 to $33.

Credit Suisse cuts PulteGroup (NYSE: PHM) from Outperform to Neutral.

UBS chops Alcatel-Lucent (NYSE: ALU) from Neutral to Sell.

Janney Montgomery Scott drops Wendy's (Nasdaq: WEN) from Buy to Neutral, lowering its price target by 50 cents to $4.75.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Guggenheim assumes coverage on Citi (NYSE: C) at Buy and $45 price target.

JPMorgan initiates ZAGG Incorporated (Nasdaq: ZAGG) with an Overweight and $13.50 target.

Cowen starts Avanir Pharmaceuticals (Nasdaq: AVNR) at Outperform.

Lazard Capital begins CIENA (Nasdaq: CIEN) with a Neutral rating.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Special Reports

Related Entities

Credit Suisse, Piper Jaffray, UBS, JPMorgan, Citi, Lazard, RBC Capital, Janney Montgomery Scott, Notable Analyst Rating Changes, Cowen & Co

Add Your Comment